We are live on
!
Find out more
AAP
Arax Advisory Partners Portfolio holdings
AUM
$3.54B
1-Year Est. Return
19.14%
This Fund
S&P 500
This Quarter
Est. Return
+8.62%
1 Year Est. Return
+19.14%
3 Year Est. Return
+47.9%
5 Year Est. Return
+48.74%
10 Year Est. Return
–
AUM
$6.97B
AUM Growth
+$4.79B
(+220%)
Cap. Flow
+$6.91B
Cap. Flow
% of AUM
99.25%
Top 10 Holdings %
Top 10 Hldgs %
36.51%
Holding
4,400
New
1,370
Increased
1,985
Reduced
143
Closed
794
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P 100 ETF
OEF
|
+$2.43B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.24B |
| 3 |
DFAI
Dimensional International Core Equity Market ETF
DFAI
|
+$202M |
| 4 |
American Century Diversified Corporate Bond ETF
KORP
|
+$152M |
| 5 |
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
|
+$144M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Growth ETF
VUG
|
+$91.2M |
| 2 |
Vanguard Morningstar Value ETF
VTV
|
+$62.6M |
| 3 |
AXON
Axon Enterprise
AXON
|
+$58.1M |
| 4 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$46.5M |
| 5 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$44.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.48% |
| 2 | Financials | 8.05% |
| 3 | Industrials | 7.03% |
| 4 | Consumer Discretionary | 6.62% |
| 5 | Healthcare | 6.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
UFP Industries
UFPI
$5.24B
| $89.1K | ﹤0.01% |
952
+281
| +42% | +$28.4K |
|
1577
Oil-Dri
ODC
$1.42B
| $88.7K | ﹤0.01% |
1,453
+663
| +84% | +$40.3K |
|
1578
Utz Brands
UTZ
$1.25B
| $88.2K | ﹤0.01% |
7,259
+3,083
| +74% | +$40.8K |
|
1579
Nuveen Dynamic Municipal Opportunities Fund
NDMO
$602M
| $88.2K | ﹤0.01% |
+8,485
| New | +$85.1K |
|
1580
Lumentum
LITE
$66.1B
| $87.5K | ﹤0.01% |
538
-154
| -22% | -$19.2K |
|
1581
Kaiser Aluminum
KALU
$2.85B
| $87.5K | ﹤0.01% |
1,134
+994
| +710% | +$79K |
|
1582
Tandem Diabetes Care
TNDM
$1.38B
| $86.8K | ﹤0.01% |
7,151
+6,675
| +1,402% | +$90.4K |
|
|
INFA
1583
DELISTED
Informatica
INFA
| $86.8K | ﹤0.01% |
3,494
+3,336
| +2,111% | +$82.3K |
|
|
TVRD
1584
Tvardi Therapeutics
TVRD
$19M
| $86.8K | ﹤0.01% |
2,227
+1,360
| +157% | +$38.7K |
|
1585
CRA International
CRAI
$1.17B
| $86.7K | ﹤0.01% |
415
+128
| +45% | +$24.6K |
|
1586
Insperity
NSP
$2.02B
| $86.2K | ﹤0.01% |
+1,753
| New | +$96K |
|
|
LPRO
1587
DELISTED
Open Lending Corp
LPRO
| $86.1K | ﹤0.01% |
+40,809
| New | +$92.2K |
|
1588
Keros Therapeutics
KROS
$203M
| $86K | ﹤0.01% |
+5,435
| New | +$80.3K |
|
1589
Standex International
SXI
$3.91B
| $85.5K | ﹤0.01% |
403
-248
| -38% | -$46.8K |
|
1590
Sanmina
SANM
$11.1B
| $85.5K | ﹤0.01% |
743
+721
| +3,277% | +$81.1K |
|
1591
Medifast
MED
$145M
| $85.4K | ﹤0.01% |
6,241
+5,825
| +1,400% | +$81.4K |
|
|
NBIS
1592
Nebius Group N.V.
NBIS
$57.3B
| $85.4K | ﹤0.01% |
+761
| New | +$52.8K |
|
1593
Vanda Pharmaceuticals
VNDA
$321M
| $85.2K | ﹤0.01% |
17,068
+16,447
| +2,648% | +$76.1K |
|
1594
BCB Bancorp
BCBP
$159M
| $84.5K | ﹤0.01% |
9,738
+9,376
| +2,590% | +$81.9K |
|
|
HONE
1595
DELISTED
HarborOne Bancorp
HONE
| $84.1K | ﹤0.01% |
6,184
+5,946
| +2,498% | +$74.3K |
|
1596
Pagaya Technologies
PGY
$1.83B
| $84K | ﹤0.01% |
+2,829
| New | +$91.4K |
|
1597
Ericsson
ERIC
$33.7B
| $84K | ﹤0.01% |
10,154
+9,125
| +887% | +$71.4K |
|
|
ARI
1598
Apollo Commercial Real Estate
ARI
$889M
| $83.9K | ﹤0.01% |
+8,281
| New | +$84.4K |
|
1599
Vishay Intertechnology
VSH
$5.96B
| $83.8K | ﹤0.01% |
5,480
+3,980
| +265% | +$63.1K |
|
1600
DHT Holdings
DHT
$2.92B
| $83.8K | ﹤0.01% |
7,015
+6,815
| +3,408% | +$79K |
|
Similar funds
TYCC
TH
ACA
BCP
WWA
VPC
BPS
TCM
Arax Advisory Partners's Q3 2025 Portfolio in Review
As of Q3 2025, Arax Advisory Partners held 4,400 positions worth $6.97B, up 220% from $2.18B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Arax Advisory Partners deployed $6.91B of net new capital in Q3 2025, opening 1,370 new positions and adding to 1,985 existing holdings. Its largest new stake was American Century Diversified Corporate Bond ETF: 3,224,236 shares worth $194M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 6.5% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Axon Enterprise, an estimated $58.1M trimmed.
- Arax Advisory Partners's largest Q3 2025 buy was American Century Diversified Corporate Bond ETF: 3,224,236 shares worth $194M.
- Arax Advisory Partners added most to iShares S&P 100 ETF in Q3 2025, an estimated $2.43B increase.
- Arax Advisory Partners's biggest Q3 2025 reduction was Axon Enterprise, cutting an estimated $58.1M.
- Arax Advisory Partners fully exited Vanguard Morningstar Growth ETF in Q3 2025, selling an estimated $91.2M.
- Arax Advisory Partners's ten largest holdings make up 37% of its $6.97B portfolio in Q3 2025.
- Arax Advisory Partners opened 1,370 new positions and closed 794 in Q3 2025.
- Arax Advisory Partners's portfolio value rose 220% quarter-over-quarter to $6.97B.
Based on Arax Advisory Partners's 13F filing for Q3 2025, filed 14 Nov 2025.